Aberdeen Asset Management plc (LON:ADN)‘s stock had its “buy” rating reiterated by Shore Capital Stockbrokers in a research note issued on Monday, AR Network reports.
Several other analysts have also recently commented on the stock. Analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Aberdeen Asset Management plc (LON:ADN) in a research note to investors on Monday. They now have a GBX 480 ($7.69) price target on the stock. Separately, analysts at RBC Capital reiterated an “outperform” rating on shares of Aberdeen Asset Management plc (LON:ADN) in a research note to investors on Monday, September 16th. They now have a GBX 495 ($7.93) price target on the stock.
One research analyst has rated the stock with a sell rating, four have given a hold rating and seventeen have issued a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of GBX 481.16 ($7.71).
Aberdeen Asset Management plc (LON:ADN) opened at 396.4537 on Monday. Aberdeen Asset Management plc has a one year low of GBX 304.60 and a one year high of GBX 492.20. The stock has a 50-day moving average of GBX 373.8 and a 200-day moving average of GBX 410.2. The company’s market cap is £4.508 billion.
Aberdeen Asset Management PLC is an international asset management company investing across the four main asset classes of equity, fixed income, property and alternative investment strategies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.